BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1085739)

  • 41. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The study on the specific eruptions of malignant lymphoma. I. Clinical, pathological and immunopathological characters].
    Iijima S; Baba T; Ueno K
    Nihon Hifuka Gakkai Zasshi; 1990 Mar; 100(4):503-15. PubMed ID: 2370704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-Hodgkin's malignant lymphoma: reliability of "typing" using cyto-enzymatic markers. Comparison with immunological markers (author's transl)].
    Micheau C; Bernard A; Pujade E; Belpomme D; Carlu C; Clausse B
    Nouv Presse Med; 1980 Jan; 9(3):167-70. PubMed ID: 6965535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The significance of the enzyme histochemistry in the diagnosis of malignant non-Hodgkin's lymphomas (author's transl)].
    Rath FW
    Arch Geschwulstforsch; 1979; 49(8):702-14. PubMed ID: 396900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunological diagnosis of cutaneous lymphomas. II. Membrane receptor for Helix pomatia lectin on lymphocytes: a new immunohistological marker for T-lymphocytes and Sezary cells].
    Trost TH
    Z Hautkr; 1985 Jan; 60(1-2):67-70. PubMed ID: 3885601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
    Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
    Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathogneses of cutaneous malignant lymphoma].
    Steigleder GK
    Z Hautkr; 1978 Oct; 53(20):719-26. PubMed ID: 309693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin imprint cytology in the diagnosis of cutaneous T-cell lymphomas. A preliminary report.
    Rosen SE; Koprowska I; Vonderheid EC
    Acta Cytol; 1982; 26(6):819-22. PubMed ID: 6186110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Classification and prognosis of cutaneous T-cell lymphomas].
    Kerl H; Hödl S; Smolle J; Konrad K
    Z Hautkr; 1986 Jan; 61(1-2):63-7. PubMed ID: 3485330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Malignant histiocytosis with cutaneous involvement: enzymecytochemical and immunocytological studies (author's transl)].
    Büchner SA; Rufli T
    Dtsch Med Wochenschr; 1980 Mar; 105(11):373-7. PubMed ID: 7363775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin.
    Burg G; Kerl H; Schmoeckel C
    J Dermatol Surg Oncol; 1984 Apr; 10(4):271-5. PubMed ID: 6608539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification and differentiation of cutaneous lymphomas. Enzyme-cytochemical and immunocytological studies.
    Burg G; Braun-Falco O
    Br J Dermatol; 1975 Nov; 93(5):597-9. PubMed ID: 1106755
    [No Abstract]   [Full Text] [Related]  

  • 57. Histologic identification of malignant lymphoma cutis.
    Fisher ER; Park EJ; Wechsler HL
    Am J Clin Pathol; 1976 Feb; 65(2):149-58. PubMed ID: 766605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    J Dermatol Surg Oncol; 1984 Apr; 10(4):306-12. PubMed ID: 6608543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphadenosis benigna cutis versus primary cutaneous B-cell lymphomas of follicular center cell origin.
    Rijlaarsdam JU; Meijer CJ; Willemze R
    Curr Probl Dermatol; 1990; 19():189-95. PubMed ID: 2404676
    [No Abstract]   [Full Text] [Related]  

  • 60. Alkaline phosphatase positive lymphoma.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    Dermatologica; 1984; 169(6):342-7. PubMed ID: 6335434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.